iData Insights

Molecular Diagnostics Market by Application Forecast to 2020 Now Available at iData Insights

News   •   Dec 18, 2015 16:34 IST

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate. The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments. On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the market in 2015. Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period. The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market. Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioM?rieux SA (France), and Cepheid Inc. (U.S.).

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

1 Introduction (Page No. - 25)

1.1 Objectives of the Study

1.2 Market Definition

1.3 Markets Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Stakeholders

2 Research Methodology (Page No. - 29)

2.1 Market Size Estimation

2.2 Market Breakdown and Data Triangulation

2.2.1 Key Data From Secondary Sources

2.2.2 Key Data From Primary Sources Key Industry Insights

2.2.3 Assumptions

3 Executive Summary (Page No. - 37)

4 Premium Insights (Page No. - 43)

4.1 Molecular Diagnostics Market

4.2 Market,Infectious Diseases

4.3 Market, By Technology and Application

4.4 Market, By End User

4.5 Market, By Products and Services

5 Market Overview (Page No. - 47)

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers High Prevalence Rate of Infectious Diseases and Various Types of Cancer Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics Development of Biomarker Identification and Advancements in Molecular Techniques Growth in Proteomics and Genomics Research Reforms in the Reimbursement System in the U.S.

5.2.2 Restraints Molecular Diagnostic Tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests

5.2.3 Opportunities Advances in Genomics Significant Growth Prospects in Developing Countries

5.2.4 Challenge Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application (Page No. - 56)

6.1 Introduction

6.2 Infectious Diseases

6.2.1 Hepatitis B

6.2.2 Hepatitis C

6.2.3 Human Immunodeficiency Virus (HIV)

6.2.4 Tuberculosis (TB)

6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)

6.2.6 Human Papillomavirus (HPV)

6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)

6.2.8 Others

6.3 Oncology

6.3.1 Prostate Cancer

6.3.2 Breast Cancer

6.4 Colorectal Cancer

6.5 Others

6.6 Genetic Tests

6.7 Blood Screening

6.8 Microbiology

6.9 Others

7 Molecular Diagnostics Market, By Technology (Page No. - 87)

7.1 Introduction

7.2 Polymerase Chain Reaction (PCR)

7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

7.4 Microarrays

7.5 Hybridization (In-Situ Hybridization & Fish)

7.6 DNA Sequencing and Next-Generation Sequencing

7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services (Page No. - 110)

8.1 Introduction

8.2 Reagents

8.3 Instruments

8.4 Software & Services

9 Molecular Diagnostics Market, By End User (Page No. - 124)

9.1 Introduction

9.2 Hospital/Academic Laboratories

9.3 Reference Laboratories

9.4 Other End Users

10 Molecular Diagnostic Market, By Region (Page No. - 136)

10.1 Introduction

10.2 North America

10.2.1 U.S.

10.2.2 Canada

10.3 Europe

10.3.1 U.K.

10.3.2 Germany

10.3.3 France

10.3.4 Italy

10.3.5 Spain

10.3.6 Rest of Europe (RoE)

10.4 Asia

10.4.1 Japan

10.4.2 India

10.4.3 China

10.4.4 Rest of Asia (RoA)

10.5 Rest of the World (RoW)

10.5.1 Latin America Mexico Brazil Rest of Latin America (RoLA)

10.5.2 Pacific Countries

10.5.3 Middle East & Africa

11 Competitive Landscape (Page No. - 192)

11.1 Overview

11.2 Market Share Analysis

11.3 Molecular Diagnostics Market Competitor Share Analysis, By Application

11.3.1 Market Share Analysis for Infectious Disease Diagnostics Applications

11.3.2 Market Share Analysis for Blood Screening Applications

11.3.3 Market Share Analysis for Microbiology Applications

11.3.4 Market Share Analysis for Oncology Applications

11.3.5 Market Share Analysis for Genetic Testing Applications

11.4 Molecular Diagnostics Market Share Analysis, By Technology

11.4.1 Polymerase Chain Reaction (PCR)

11.4.2 DNA Sequencing and Ngs

11.4.3 Microarray

11.4.4 Hybridization (In Situ and Fluorescence)

11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)

11.5 Product Approvals

11.6 Agreements, Collaborations, and Partnerships

11.7 New Product Launches

11.8 Acquisitions

11.9 Other Developments

12 Company Profiles (Page No. - 208)

12.1 Introduction

12.2 Abbott Laboratories

12.2.1 Business Overview

12.2.2 Abbott Laboratories: Company Snapshot

12.2.3 Products Offered

12.2.4 Recent Developments

12.2.5 MnM View

12.3 Qiagen N.V.

12.3.1 Business Overview

12.3.2 Qiagen N.V.: Company Snapshot

12.3.3 Products & Services Offered

12.3.4 Recent Developments

12.3.5 MnM View

12.4 Roche Diagnostics

12.4.1 Business Overview

12.4.2 Roche Diagnostics: Company Snapshot

12.4.3 Products Offered

12.4.4 Recent Developments

12.4.5 MnM View

12.5 Hologic, Inc.

12.5.1 Business Overview

12.5.2 Hologic, Inc.: Company Snapshot

12.5.3 Products Offered

12.5.4 Recent Developments

12.5.5 MnM View

12.6 Grifols

12.6.1 Business Overview

12.6.2 Grifols: Company Snapshot

12.6.3 Products Offered

12.6.4 Recent Developments

12.6.5 MnM View

12.7 Siemens Healthcare

12.7.1 Business Overview

12.7.2 Siemens Healthcare: Company Snapshot

12.7.3 Products Offered

12.7.4 Recent Developments

12.8 Becton, Dickinson and Company

12.8.1 Business Overview

12.8.2 Becton, Dickinson and Company: Company Snapshot

12.8.3 Products & Services Offered

12.8.4 Recent Developments

12.9 Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)

12.9.1 Business Overview

12.9.2 Danaher Corporation: Company Snapshot

12.9.3 Products & Services Offered

12.9.4 Recent Developments

12.10 Biom?rieux SA

12.10.1 Business Overview

12.10.2 Biom?rieux: Company Snapshot

12.10.3 Products Offered

12.10.4 Recent Developments

12.11 Cepheid Inc.

12.11.1 Business Overview

12.11.2 Cepheid Inc.: Company Snapshot

12.11.3 Products Offered

12.11.4 Recent Developments

13 Appendix (Page No. - 263)

13.1 Insights of Industry Experts

13.2 Discussion Guide

13.3 Other Developments

13.3.1 Abbott Laboratories

13.3.2 Qiagen N.V.

13.3.3 Roche Diagnostics

13.3.4 Hologic Inc.

13.3.5 Hologic Inc.

13.3.6 Siemens Healthcare

13.3.7 Becton, Dickinson and Company

13.3.8 Becton, Dickinson and Company

13.4 Introducing RT: Real-Time Market Intelligence

13.5 Available Customizations

13.6 Related Reports

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects